Evaluation of Technological Innovation in Radiotherapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
About this trial
Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes.
The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice.
Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ability to provide informed consent
Receiving radiotherapy or brachytherapy
Disqualifiers
None
Trial population
Patients receiving standard-care radiotherapy at CHUM
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Accrual rates
Determine feasibility of achieving high accural rates (greater than 80%) with this approach.
Time frame
2 yearsSecondary outcomes
1
Number of cmRCT trials activated
Measure if success would be the activation of 2 or more trials in the time frame.
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov